Vistin Pharma ASA (OSL:VISTN) Cyclically Adjusted Book per Share: kr8.97 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:VISTN Vistin Pharma ASA OSL:VISTN
80 GF Score
Price kr19.30
GF Value kr23.39
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Vistin Pharma ASA Cyclically Adjusted Book per Share?

Vistin Pharma ASA OSL:VISTN -4.46% 80 Cyclically Adjusted Book per Share is kr8.97 as of Jun. 2026. GuruFocus rates OSL:VISTN with a GF Score™ of 80/100 and a GF Value™ of kr23.39 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Vistin Pharma ASA's adjusted book value per share for the three months ended in Jun. 2026 was kr7.218. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr8.97 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Vistin Pharma ASA's average Cyclically Adjusted Book Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-21), Vistin Pharma ASA's current stock price is kr19.30. Vistin Pharma ASA's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was kr8.97. Vistin Pharma ASA's Cyclically Adjusted PB Ratio of today is 2.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vistin Pharma ASA was 2.94. The lowest was 2.15. And the median was 2.48.


Vistin Pharma ASA  (OSL:VISTN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vistin Pharma ASA's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=19.30/8.97
=2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vistin Pharma ASA was 2.94. The lowest was 2.15. And the median was 2.48.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Vistin Pharma ASA Cyclically Adjusted Book per Share Related Terms


Vistin Pharma ASA Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Vistin Pharma ASA's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vistin Pharma ASA Cyclically Adjusted Book per Share Chart

Vistin Pharma ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 9.45 9.18

Vistin Pharma ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.44 9.32 9.18 9.13 8.97

OSL:VISTN vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vistin Pharma ASA Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vistin Pharma ASA's Cyclically Adjusted PB Ratio falls into.


OSL:VISTN
80GF Score
Vistin Pharma ASA OSL:VISTN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vistin Pharma ASA Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vistin Pharma ASA's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=7.218/141.5800*141.5800
=7.218

Current CPI (Jun. 2026) = 141.5800.

Vistin Pharma ASA Quarterly Data

Book Value per Share CPI Adj_Book
201609 11.154 104.200 15.155
201612 10.708 104.400 14.521
201703 10.932 105.000 14.741
201706 10.272 105.800 13.746
201709 10.455 105.900 13.978
201712 6.895 106.100 9.201
201803 7.388 107.300 9.748
201806 9.292 108.500 12.125
201809 9.244 109.500 11.952
201812 7.867 109.800 10.144
201903 7.849 110.400 10.066
201906 7.859 110.600 10.060
201909 9.203 111.100 11.728
201912 9.322 111.300 11.858
202003 6.372 111.200 8.113
202006 5.840 112.100 7.376
202009 5.942 112.900 7.451
202012 6.143 112.900 7.704
202103 6.341 114.600 7.834
202106 6.023 115.300 7.396
202109 6.046 117.500 7.285
202112 6.219 118.900 7.405
202203 5.877 119.800 6.945
202206 5.882 122.600 6.793
202209 5.731 125.600 6.460
202212 6.167 125.900 6.935
202303 6.095 127.600 6.763
202306 6.260 130.400 6.797
202309 6.790 129.800 7.406
202312 7.279 131.900 7.813
202403 6.701 132.600 7.155
202406 6.634 133.800 7.020
202409 7.007 133.700 7.420
202412 6.980 134.800 7.331
202503 7.469 136.100 7.770
202506 6.636 137.800 6.818
202509 7.054 138.500 7.211
202512 7.415 139.100 7.547
202603 7.900 141.030 7.931
202606 7.218 141.580 7.218

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr8.97 mean?
Vistin Pharma ASA (OSL:VISTN) has a Cyclically Adjusted Book per Share of kr8.97 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vistin Pharma ASA and its competitors.
Is Vistin Pharma ASA's Cyclically Adjusted Book per Share too high?
Vistin Pharma ASA's current Cyclically Adjusted Book per Share is kr8.97. Overall, Vistin Pharma ASA has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vistin Pharma ASA's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Vistin Pharma ASA's Cyclically Adjusted Book per Share of kr8.97 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vistin Pharma ASA and its competitors. Vistin Pharma ASA's current Cyclically Adjusted Book per Share is kr8.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vistin Pharma ASA stock overvalued right now?
Based on GuruFocus' analysis, Vistin Pharma ASA (OSL:VISTN) is currently considered Modestly Undervalued. The stock's GF Value™ is kr23.39, compared to a current price of kr19.30 — trading 17.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is kr8.97. Vistin Pharma ASA's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Vistin Pharma ASA (OSL:VISTN), the current Cyclically Adjusted Book per Share is kr8.97 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vistin Pharma ASA (OSL:VISTN) Overvalued in 2026?

Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued. The current stock price of kr19.30 is trading 17.5% below its estimated GF Value™ of kr23.39. GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.

Key valuation signals for OSL:VISTN:

  • Cyclically Adjusted Book per Share: kr8.97
  • GF Value™: kr23.39 vs. price of kr19.30 (17.5% below fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the OSL:VISTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vistin Pharma ASA Business Description

Address Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
80GF Score

Get the complete analysis for OSL:VISTN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr19.30
Price
kr23.39
GF Value